Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 1612
TargetOrexin receptor type 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332759(US10196383, Example 2)
Affinity DataIC50: 169nMAssay Description:The capability of the compounds to antagonism of humanized OX2 receptor transfected by the HEK-293 cells was evaluated by the method of fluorescence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin receptor type 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332761(US10196383, Example 6)
Affinity DataIC50: 221nMAssay Description:The capability of the compounds to antagonism of humanized OX2 receptor transfected by the HEK-293 cells was evaluated by the method of fluorescence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin receptor type 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332760(US10196383, Example 5)
Affinity DataIC50: 263nMAssay Description:The capability of the compounds to antagonism of humanized OX2 receptor transfected by the HEK-293 cells was evaluated by the method of fluorescence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332760(US10196383, Example 5)
Affinity DataIC50: 276nMAssay Description:The capability of the compounds to the antagonism of humanized OX1 receptor transfected to the Chinese hamster ovary (CHO) cells was evaluated by the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin receptor type 2(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332758(US10196383, Example 1)
Affinity DataIC50: 300nMAssay Description:The capability of the compounds to antagonism of humanized OX2 receptor transfected by the HEK-293 cells was evaluated by the method of fluorescence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332758(US10196383, Example 1)
Affinity DataIC50: 322nMAssay Description:The capability of the compounds to the antagonism of humanized OX1 receptor transfected to the Chinese hamster ovary (CHO) cells was evaluated by the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332761(US10196383, Example 6)
Affinity DataIC50: 367nMAssay Description:The capability of the compounds to the antagonism of humanized OX1 receptor transfected to the Chinese hamster ovary (CHO) cells was evaluated by the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM332759(US10196383, Example 2)
Affinity DataIC50: 543nMAssay Description:The capability of the compounds to the antagonism of humanized OX1 receptor transfected to the Chinese hamster ovary (CHO) cells was evaluated by the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent